[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group:Conventional Treatment & Low Dose Recombinant Human Interleukin-2; i.m.(1 million IU per time; once another day; 3 times per week; 2 weeks);Control Group:Conventional Treatment+Placebo i.m.(once another day; 3 times per week; 2 weeks);", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group:Conventional Treatment & Low Dose Recombinant Human Interleukin-2; i.m.(1 million IU per time; once another day; 3 times per week; 2 weeks)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group:Conventional Treatment+Placebo i.m.(once another day; 3 times per week; 2 weeks);", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1079, "treatment_name": "Recombinant human interleukin-2", "treatment_type": "Interleukins", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]